跳至主要内容
临床试验/IRCT20221101056363N1
IRCT20221101056363N1招募中3 期

Clinical trial of hybrid thermosensitive hydrogel based on hyaluronic acid containing celecoxib for knee osteoarthritis patients

Mashhad University of Medical Sciences0 个研究点目标入组 84 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 years 至 80 years(—)
性别
All

入选标准

  • Primary one-sided osteoarthritis of the knee that has been at least 6 months since it became symptomatic (painful) and aggravated by weight bearing and has not responded properly to conservative treatment.
  • Radiographic arthrosis stage 1, 2 and 3 of Kellgren Lawrence classification (KLS)
  • Signing the consent form and complete and voluntary willingness to participate in the study

排除标准

  • Any history of trauma (fracture), surgery and tumor in the knee and lower limb of the same side
  • Clinically obvious alignment disorder
  • Any history of invasive procedure, injection or infection in the desired knee during the last 6 months
  • Any blood disorder
  • History or history of autoimmune disease or being treated with immunosuppressors and non-removable corticosteroids
  • Patients with secondary osteoarthritis
  • Proven liver and kidney disorders
  • Irrevocable consumption of oral or topical painkillers
  • Cognitive impairments and the inability to walk without a walker or the help of others
  • CVA and similar problemsInsulin-dependent diabetic patients
  • Patients with spine disorders and radicular pain to the lower limbs

研究者

相似试验